COVID-19 International Drug Pregnancy Registry

RecruitingOBSERVATIONAL

Enrollment

2,000

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

September 30, 2027

Study Completion Date

September 30, 2027

Conditions

Covid19

Interventions

DRUG

Antiviral Agents

Antiviral medications indicated for the treatment of mild to severe COVID-19

DRUG

Monoclonal antibody

Monoclonal antibodies indicated for the treatment of mild to severe COVID-19

Trial Locations (1)

RECRUITING

Pregistry, Los Angeles

All Listed Sponsors

lead

Pregistry

INDUSTRY